Skip to main content
letter
. 2021 Feb 9;200:128–129. doi: 10.1016/j.thromres.2021.01.025

Fig. 1.

Fig. 1

Forest plot of overall bleedings risk ratio between fondaparinux and enoxaparin.

Test for overall effect: Z-score: 1.53; P = 0.125

Test for heterogeneity: chi-squared: 1.19; P = 0.276; I2: 15.8%.